Stock Analysis

Analysts Have Lowered Expectations For IPG Photonics Corporation (NASDAQ:IPGP) After Its Latest Results

NasdaqGS:IPGP
Source: Shutterstock

There's been a notable change in appetite for IPG Photonics Corporation (NASDAQ:IPGP) shares in the week since its annual report, with the stock down 12% to US$88.99. Results were roughly in line with estimates, with revenues of US$1.3b and statutory earnings per share of US$4.63. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

See our latest analysis for IPG Photonics

earnings-and-revenue-growth
NasdaqGS:IPGP Earnings and Revenue Growth February 16th 2024

Following the recent earnings report, the consensus from ten analysts covering IPG Photonics is for revenues of US$1.17b in 2024. This implies an uncomfortable 9.2% decline in revenue compared to the last 12 months. Statutory earnings per share are forecast to plunge 33% to US$3.17 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.34b and earnings per share (EPS) of US$4.98 in 2024. Indeed, we can see that the analysts are a lot more bearish about IPG Photonics' prospects following the latest results, administering a substantial drop in revenue estimates and slashing their EPS estimates to boot.

The consensus price target fell 11% to US$111, with the weaker earnings outlook clearly leading valuation estimates. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on IPG Photonics, with the most bullish analyst valuing it at US$131 and the most bearish at US$74.00 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await IPG Photonics shareholders.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the IPG Photonics' past performance and to peers in the same industry. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 9.2% by the end of 2024. This indicates a significant reduction from annual growth of 1.0% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 5.2% per year. It's pretty clear that IPG Photonics' revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

With that in mind, we wouldn't be too quick to come to a conclusion on IPG Photonics. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for IPG Photonics going out to 2026, and you can see them free on our platform here..

You can also see our analysis of IPG Photonics' Board and CEO remuneration and experience, and whether company insiders have been buying stock.

Valuation is complex, but we're helping make it simple.

Find out whether IPG Photonics is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.